晚期非小细胞肺癌维持治疗的研究进展
周倩， 谭榜宪 - 中国肿瘤临床, 2021 - cjco.cn
… Research progress of maintenance therapy in advanced non-small cell lung … of advanced
NSCLC maintenance therapy and discusses the clinical significance of maintenance therapy …
NSCLC maintenance therapy and discusses the clinical significance of maintenance therapy …
吉非替尼对比培美曲塞联合顺铂治疗术后EGFR 突变阳性Ⅱ~ ⅢA 期肺腺癌的临床分析
谢厚耐， 李猛， 许林， 王晖， 彭岳… - 山东大学学报(医学 …, 2022 - yxbwk.njournal.sdu.edu.cn
… , gefitinib shows a significant DFS benefit in patients with EGFR mutation-positive and completely
resected stage Ⅱ-ⅢA lung … Non-small cell lung cancer, version 5.2017, NCCN clinical …
resected stage Ⅱ-ⅢA lung … Non-small cell lung cancer, version 5.2017, NCCN clinical …
EGFR 敏感突变的晚期肺腺癌一线化疗与吉非替尼联合治疗的随机对照研究
金波， 张岩巍， 韩宝惠 - 中国癌症杂志, 2015 - china-oncology.com
… a 4-week cycle plus gefitinib as maintenance therapy; Group B (n… 治疗晚期非小细胞肺癌
(non-small cell lung cancer,NSCLC)的重要… multicenter phase Ⅱ trial of sequential erlotinib and …
(non-small cell lung cancer,NSCLC)的重要… multicenter phase Ⅱ trial of sequential erlotinib and …
[HTML][HTML] 晚期EGFR 突变型非小细胞肺癌患者接受吉非替尼或厄洛替尼治疗的成本效益分析
马宇翔， 黄岩， 赵洪云， 刘俊玲， 陈丽昆… - … Journal of Lung …, 2013 - ncbi.nlm.nih.gov
… Targeted therapy in non-small cell lung cancer (NSCLC) had become a research hotspot.Both
of gefitinib and erlotinib had already been recommended as first line treatment in …
of gefitinib and erlotinib had already been recommended as first line treatment in …
[PDF][PDF] 澳門某醫院中醫腫瘤專科惡性腫瘤病人狀況分析
陳玉玲， 莫穗林， 曹亞兵， 劉慶生 - 鏡湖醫學, 2016 - mjokw.magtechjournal.com
… -line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced
non-small cell lung cancer in … Erlotinib versus chemotherapy (CT) in advanced non-small …
non-small cell lung cancer in … Erlotinib versus chemotherapy (CT) in advanced non-small …
[HTML][HTML] 既往吉非替尼治疗获益的晚期NSCLC 患者再次使用EGFR-TKI 的选择： 原药还是换药？
汤传昊， 李晓燕， 郭万峰， 李俭杰， 秦海峰… - … Journal of Lung …, 2013 - ncbi.nlm.nih.gov
… For advanced non-small cell lung cancer (NSCLC) patients … (EGFR-TKI) therapy, the choice
of a second TKI therapy has … between patients treated with Gefitinib and with Erlotinib, no …
of a second TKI therapy has … between patients treated with Gefitinib and with Erlotinib, no …
[PDF][PDF] 非小细胞肺癌的靶向治疗策略
姚舒洋， 张毅， 支修益 - 临床药物治疗杂志, 2013 - lcywzlzz.com
… growth factor receptor inhibitor gefitinib in completely resected stage IB-IIIA non-small cell …
-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer[J]. J …
-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer[J]. J …
厄洛替尼二次治疗晚期非小细胞肺癌患者的临床分析
吴标， 黄诚， 蒋侃 - 中国癌症杂志, 2015 - china-oncology.com
… advanced non-small cell lung cancer (NSCLC). But almost all … Erlotinib as maintenance
treatment in advanced non-small-… gefitinib/ chemotherapy treatment in non small cell lung cancer …
treatment in advanced non-small-… gefitinib/ chemotherapy treatment in non small cell lung cancer …
[HTML][HTML] 分子靶向药物应用于非小细胞肺癌维持治疗的研究进展
单利 - Chinese Journal of Lung Cancer, 2010 - ncbi.nlm.nih.gov
… maintenance therapy in advanced stage non-small cell lung … phase Ⅲ trial of gefitinib versus
placebo maintenance after … phase Ⅱ randomized doubleblind trial of sequential erlotinib …
placebo maintenance after … phase Ⅱ randomized doubleblind trial of sequential erlotinib …
以基因型为导向治疗改变了转移性非小细胞肺癌治疗模式
李娟， 张力建， 王跃辉， 朱步东 - Advances in Clinical Medicine, 2013 - hanspub.org
… 随着肿瘤驱动基因与临床关系的认识深化,转移性非小细胞肺癌(non-small cell lung … maintenance
treatment, second-line treatment, immunochemistry (especially the antibody) treatment …
treatment, second-line treatment, immunochemistry (especially the antibody) treatment …